Epic Bio takes aim at DUX4

Updated 12-12-24 to reflect the chance in name from Epic Bio to Epicrispr Biotechnologies. Leading-edge CRISPR biotech chooses FSHD as its first disease target Epicrispr Biotechnologies, based in the San … Continue reading Epic Bio takes aim at DUX4